Immunogenic cell death and bystander killing: expanding the therapeutic potential of modern antibody-drug conjugates
HER3-DXd and T-DXd are antibody-drug conjugates (ADCs) that induce immunogenic cell death and bystander killing, enhancing antitumor immunity beyond target-specific cytotoxicity. These findings highlight novel mechanisms that can overcome antigen heterogeneity and suggest opportunities for improving...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2025-12-01
|
| Seri Bilgileri: | OncoImmunology |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2533488 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|